KBLB
Kraig Biocraft Laboratories, Inc.Company with tickers: KBLB
CIK
1413119
CUSIP
50075W104
Shares Outstanding
1,113,049,449
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $825,500 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $66,701 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-825,500 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-942,720 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |